Changes in cardiac troponins during hemodialysis depend on hemodialysis membrane and modality: a randomized crossover trial.

Autor:	Kolland, Michael, Amenitsch, Jascha, Schreiber, Nikolaus, Ginthör, Noemi, Schuller, Max, Riedl, Regina, Rainer, Peter P, Schneditz, Daniel, Niedrist, Tobias, Eller, Kathrin, Krietemeyer, Benedikt, Rosenkranz, Alexander R, Kirsch, Alexander H
Předmět:	CROSSOVER trials CHEST pain NON-ST elevated myocardial infarction MYOCARDIAL infarction BRAIN natriuretic factor HEMODIALYSIS
Zdroj:	Clinical Kidney Journal; Jan2024, Vol. 17 Issue 1, p1-5, 5p
Abstrakt:	This article discusses the challenges of diagnosing acute coronary syndromes (ACS) in hemodialysis (HD) patients. The study aimed to explore the changes in cardiac troponin (cTn) levels during HD with different membranes and treatment modalities. The results showed significant differences in cTn changes depending on the type of membrane used. The data suggests that high-flux HD and MCO may be more effective in reducing troponin levels compared to low-flux HD and HDF. However, further research is needed to confirm these findings and establish a diagnostic algorithm for AMI in HD patients. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.